CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) has announced that it will host a virtual presentation at the Oppenheimer 35th Annual Healthcare Conference on Monday, March 17, 2025, around 9:20 a.m. (ET). The presentation will be streamed live and can be accessed, along with related materials, on the Chemed website at www.chemed.com (Investor Relations). A replay of the webcast will be available within 24 hours after the live event.
Chemed Corporation (NYSE:CHE) will hold its Q4 2024 Earnings Conference Call on February 27, 2025, at 10:00 AM ET. The call will feature company representatives including Holley Schmidt, Kevin McNamara, Mike Witzeman, and Nick Westfall, along with participants from RBC Capital Markets and Bank of America. Currently, all attendees are in listen-only mode.
Chemed (CHE) reported quarterly earnings of $6.83 per share, which is higher than the Zacks Consensus Estimate of $6.79 per share. This is an increase compared to last year's earnings of $6.60 per share.
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) has announced that its Board of Directors will pay a quarterly cash dividend of 50 cents per share on March 14, 2025, to shareholders who are on record as of February 24, 2025. This amount is the same as the dividend paid in December 2024. This marks the 215th consecutive quarterly dividend for Chemed in its 53 years as a public company, and it is listed on the New York Stock Exchange with its headquarters in Cincinnati.
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) has announced that it will share its financial results for the fourth quarter ending December 31, 2024, on Wednesday, February 26, 2025, after the New York Stock Exchange closes. The company will hold a conference call and webcast at 10 a.m. ET on Thursday, February 27, 2025, to go over the quarterly results and give a business update. Participants can join the live webcast of the conference call.
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) has announced that it will present at the 43rd Annual JPMorgan Healthcare Conference on Tuesday, January 14, 2024, around 10:30 a.m. PST at the Westin St. Francis Hotel in San Francisco, CA. The presentation will be available to watch live on the Chemed website at www.chemed.com (Investor Relations). A replay of the webcast will be accessible about three hours after the live event.
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) has announced that it will participate in the BofA Securities 2024 Virtual Home Care Conference on Tuesday, December 10, 2024, at 1:20 PM (ET). The presentation will be available to watch live on the Chemed website, along with the related materials. A replay of the webcast will be accessible within 24 hours and will remain available for 90 days.
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE:CHE) has announced that its Board of Directors has approved an extra $300 million for stock buybacks as part of its current repurchase program. The company will finance these buybacks using cash from its operations and its revolving credit line. Additionally, the Board has declared a quarterly cash dividend of 50 cents per share on the company's stock.
CINCINNATI--(BUSINESS WIRE)--Chemed Corporation (NYSE: CHE) has announced that it will present at the UBS 2024 Global Healthcare Conference on Tuesday, November 12, 2024, around 2:45 p.m. (ET) at the Terranea Resort in Rancho Palos Verdes, California. The presentation will be available to watch live online, and the materials can be found on the Chemed website at www.chemed.com (Investor Relations). A replay of the webcast will be accessible within 24 hours after the event.
Chemed's VITAS division has shown strong revenue growth and improved profit margins in the third quarter of 2024.